D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy
Positron emission tomography (PET) imaging of the C-X-C chemokine receptor 4 (CXCR4) with [<sup>68</sup>Ga]PentixaFor has intrinsic diagnostic value and is used to select patients for personalized CXCR4-targeted radionuclide therapy with its therapeutic radiopharmaceutical companion [<...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-10-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/13/10/1619 |